Harmani Kalim, M.G.F., Rohman, M.S., Sargowo, D., Winarsih, S., Nugrahenny, D., Sujuti, H., Widhaningrum, S.N. and Souhaly, J. W. 2026. Empagliflozin Attenuates Cardiac Fibrosis via Suppression of TLR2/NF-κB Signaling in a Rat Model of Metabolic Syndrome. Trends in Sciences. 23, 9 (Apr. 2026), 13423. DOI:https://doi.org/10.48048/tis.2026.13423.